NOXOPHARM LIMITED

ASX: NOX

Sector: Sector:Health Care
Industry group: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Latest NOX ASX Announcements

4 Aug 2026 · 6:18 pmCompany Update
New study further validates Noxopharms cancer pipeline
4 Aug 20266:18 pmNew study further validates Noxopharms cancer pipelineCompany Update
22 July 2026 · 6:26 pmQuarterly Reports
Quarterly Activities/Appendix 4C Cash Flow Report
22 July 20266:26 pmQuarterly Activities/Appendix 4C Cash Flow ReportQuarterly Reports
7 July 2026 · 7:34 pmCompany Update
Pre-IND meeting request with US FDA
7 July 20267:34 pmPre-IND meeting request with US FDACompany Update
2 July 2026 · 6:15 pmCompany Update
Sofr platform versatility shown via childbirth MRFF grant
2 July 20266:15 pmSofr platform versatility shown via childbirth MRFF grantCompany Update
1 July 2026 · 7:50 pmCompany Update
Fast-tracking of cancer program via novel animal model
1 July 20267:50 pmFast-tracking of cancer program via novel animal modelCompany Update
9 June 2026 · 6:29 pmCompany Update
SOF-SKN manufacturing begins to ensure clinical trial readi
9 June 20266:29 pmSOF-SKN manufacturing begins to ensure clinical trial readiCompany Update
2 June 2026 · 2:23 amDirector Interests
Change of Director's Interest Notice
2 June 20262:23 amChange of Director's Interest NoticeDirector Interests
26 May 2026 · 6:21 pmCompany Update
New data confirms cancer-fighting potential
26 May 20266:21 pmNew data confirms cancer-fighting potentialCompany Update
20 May 2026 · 7:21 pmCompany Update
Noxopharms Sofra assets to be presented at global conference
20 May 20267:21 pmNoxopharms Sofra assets to be presented at global conferenceCompany Update
8 May 2026 · 7:28 pmSecurities Administration
Proposed issue of securities - NOX
8 May 20267:28 pmProposed issue of securities - NOXSecurities Administration
6 May 2026 · 6:13 pmCompany Update
Noxopharm progresses US regulatory strategy
6 May 20266:13 pmNoxopharm progresses US regulatory strategyCompany Update
1 May 2026 · 7:08 pmCompany Update
New data shows SOF-SKN active ingredient efficacy
1 May 20267:08 pmNew data shows SOF-SKN active ingredient efficacyCompany Update
30 Apr 2026 · 6:18 pmCompany Administration
New Company Secretary appointed
30 Apr 20266:18 pmNew Company Secretary appointedCompany Administration
27 Apr 2026 · 6:21 pmCompany Update
Innovative collaboration further expands Sofra platform
27 Apr 20266:21 pmInnovative collaboration further expands Sofra platformCompany Update
24 Apr 2026 · 7:23 pmQuarterly Reports
March 2026 Quarterly Activities Report and Appendix 4C
24 Apr 20267:23 pmMarch 2026 Quarterly Activities Report and Appendix 4CQuarterly Reports

View complete NOX announcement history →